Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Trulieve Cannabis (TCNNF) Minority Interest (2021 - 2025)

Trulieve Cannabis (TCNNF) has 5 years of Minority Interest data on record, last reported at -$18.2 million in Q4 2025.

  • For Q4 2025, Minority Interest fell 48.68% year-over-year to -$18.2 million; the TTM value through Dec 2025 reached -$18.2 million, down 48.68%, while the annual FY2025 figure was -$18.2 million, 48.68% down from the prior year.
  • Minority Interest reached -$18.2 million in Q4 2025 per TCNNF's latest filing, down from -$17.5 million in the prior quarter.
  • Across five years, Minority Interest topped out at $7.7 million in Q1 2024 and bottomed at -$18.2 million in Q4 2025.
  • Average Minority Interest over 5 years is -$7.1 million, with a median of -$5.9 million recorded in 2023.
  • Peak YoY movement for Minority Interest: crashed 667.08% in 2023, then skyrocketed 253.02% in 2024.
  • A 5-year view of Minority Interest shows it stood at $1.6 million in 2021, then crashed by 322.68% to -$3.5 million in 2022, then crashed by 69.56% to -$5.9 million in 2023, then plummeted by 109.16% to -$12.3 million in 2024, then tumbled by 48.68% to -$18.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Minority Interest were -$18.2 million in Q4 2025, -$17.5 million in Q3 2025, and -$15.6 million in Q2 2025.